Cyber Monday saleUp to 70% OFF
SSS

STAR COMBO PHARMA LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

S66 chart


Full chart

Key stats


Market capitalization
‪18.90 M‬ AUD
Dividend yield (indicated)
2.64%
Price to earnings Ratio (TTM)
23.635
Basic EPS (TTM)
0.005 AUD
Net income (FY)
‪747.33 K‬ AUD
Revenue (FY)
‪26.02 M‬ AUD
Shares float
‪30.52 M‬
Beta (1Y)
0.27

About STAR COMBO PHARMA LIMITED


Sector
Health Technology
CEO
Su Zhang
Headquarters
Smithfield
Website
starcombo.com.au
Founded
2016
ISIN
AU0000004798
FIGI
BBG00K4LGNJ6
Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. It operates through the segments: Star Combo and Austoyou. The Star Combo engages in developing, manufacturing, marketing and sale of natural health supplements and ski8n care products. The Austoyou segment offers product lines to Chinese health product consumers. The company was founded by Star Zhang in 2004 and is headquartered in Smithfield, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

S66 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of S66 is 0.140 AUD — it has increased by 7.69% in the past 24 hours. Watch STAR COMBO PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange STAR COMBO PHARMA LIMITED stocks are traded under the ticker S66.
S66 stock has risen by 16.67% compared to the previous week, the month change is a −6.67% fall, over the last year STAR COMBO PHARMA LIMITED has showed a 40.00% increase.
S66 reached its all-time high on May 22, 2018 with the price of 2.030 AUD, and its all-time low was 0.090 AUD and was reached on Jul 5, 2023. View more price dynamics on S66 chart.
See other stocks reaching their highest and lowest prices.
S66 stock is 7.14% volatile and has beta coefficient of 0.27. Track STAR COMBO PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is STAR COMBO PHARMA LIMITED there?
Yes, you can track STAR COMBO PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
S66 net income for the last half-year is ‪621.63 K‬ AUD, while the previous report showed ‪125.70 K‬ AUD of net income which accounts for 394.51% change. Track more STAR COMBO PHARMA LIMITED financial stats to get the full picture.
Yes, S66 dividends are paid annually. The last dividend per share was 0.00 AUD. As of today, Dividend Yield (TTM)% is 2.64%. Tracking STAR COMBO PHARMA LIMITED dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STAR COMBO PHARMA LIMITED EBITDA is ‪999.32 K‬ AUD, and current EBITDA margin is 6.80%. See more stats in STAR COMBO PHARMA LIMITED financial statements.
Like other stocks, S66 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAR COMBO PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STAR COMBO PHARMA LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STAR COMBO PHARMA LIMITED stock shows the neutral signal. See more of STAR COMBO PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.